Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers

Inclusion Criteria: * Healthy male volunteers between the ages of 20 and 50 and within 20% of their ideal body weight, without congenital abnormality or chronic disease Exclusion Criteria: * History of cardiovascular, pulmonary, renal, endogenous, gastrointestinal, hematologic, neurologic or hemorrhagic disease; * Clinically significant findings on routine laboratory (hematology, serum chemistry and urinalysis) or ECG tests; * Use of prescription drugs in the 14 days immediately prior to starting the study that had the potential to interact with the study medication; * Use of any substance that could induce or inhibit drug metabolism enzymes